Cychlorphine is a synthetic opioid which presents a new threat to public health. In the Journal of Pain Research , a study published in July highlights the lethality of a recent wave of nitazenes. First synthesized in the 1950s but never approved for medical use, these potent 2‐benzylbenzimidazole opioids have seen a sharp rise in analogs after scheduling by the Chinese government in July 2025. Nitazenes went down, but the analogs went up.
No takes yet. Share an insight, caveat, or question.
Alison Knopf (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: